Stephan Ladisch, M.D., professor of pediatrics and professor of biochemistry and molecular biology, was featured in Medical Xpress for recently published research in the American Society of Hematology journal, Blood. The international study found that prolonged, intense initial treatment in children with multi-system Langerhans cell histiocytosis (MS-LCH) can achieve survival rates as high as 84 percent—a full 15 percent improvement over his previous clinical trial. This research was also featured in Science Codex.
Medical Xpress - Study Shows Longer Treatment for Children With Langerhans Cell Hystiocytosis Improves Survival Rates
Latest News
A new research study led by Pedro Gazzinelli Guimaraes, PhD, assistant professor of microbiology, immunology, and tropical medicine, titled “Unraveling the Hidden Regulator: Deciphering Endogenous Retroelement Control of Allergic Type 2 Immune Response,” seeks to understand how dormant viruses in…
George Washington University (GW) School of Medicine and Health Sciences faculty members Andrea A. Anderson, MD, MEd ’23, and Wanda K. Nicholson, MD, MPH, MBA, along with GW Law Dean and Harold H. Green Professor of Law Dayna Bowen Matthew, JD, PhD, were among the 90 regular members and 10…
The George Washington University’s 8th Annual Cardiovascular Symposium, organized by the GW Heart & Vascular Institute, took place on Saturday, Nov. 1, 2025 at the American College of Cardiology Heart House in Washington, DC.